Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Ansell JE, Bakhru SH, Laulicht BE, Steiner SS, Grosso MA, Brown K, Dishy V, Lanz HJ, Mercuri MF, Noveck RJ, Costin JC.

Thromb Haemost. 2017 Jan 26;117(2):238-245. doi: 10.1160/TH16-03-0224. Epub 2016 Nov 17.

PMID:
27853809
2.

Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin.

Ansell JE, Laulicht BE, Bakhru SH, Hoffman M, Steiner SS, Costin JC.

Thromb Res. 2016 Oct;146:113-118. doi: 10.1016/j.thromres.2016.07.008. Epub 2016 Jul 18.

PMID:
27470323
3.

Nonclinical Safety Assessment of PER977: A Small Molecule Reversal Agent for New Oral Anticoagulants and Heparins.

Sullivan DW Jr, Gad SC, Laulicht B, Bakhru S, Steiner S.

Int J Toxicol. 2015 Jul-Aug;34(4):308-17. doi: 10.1177/1091581815590667. Epub 2015 Jun 15.

PMID:
26079256
4.

Reversal agents in development for the new oral anticoagulants.

Costin J, Ansell J, Laulicht B, Bakhru S, Steiner S.

Postgrad Med. 2014 Nov;126(7):19-24. doi: 10.3810/pgm.2014.11.2829. Review.

PMID:
25387210
5.

Use of PER977 to reverse the anticoagulant effect of edoxaban.

Ansell JE, Bakhru SH, Laulicht BE, Steiner SS, Grosso M, Brown K, Dishy V, Noveck RJ, Costin JC.

N Engl J Med. 2014 Nov 27;371(22):2141-2. doi: 10.1056/NEJMc1411800. Epub 2014 Nov 5. No abstract available.

6.

Simple battery armor to protect against gastrointestinal injury from accidental ingestion.

Laulicht B, Traverso G, Deshpande V, Langer R, Karp JM.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16490-5. doi: 10.1073/pnas.1418423111. Epub 2014 Nov 3.

7.

Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine?

Reineke J, Cho DY, Dingle YL, Cheifetz P, Laulicht B, Lavin D, Furtado S, Mathiowitz E.

J Control Release. 2013 Sep 28;170(3):477-84. doi: 10.1016/j.jconrel.2013.05.043. Epub 2013 Jun 21.

PMID:
23796432
8.

Quick-release medical tape.

Laulicht B, Langer R, Karp JM.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18803-8. doi: 10.1073/pnas.1216071109. Epub 2012 Oct 29.

9.

Bioinspired bioadhesive polymers: dopa-modified poly(acrylic acid) derivatives.

Laulicht B, Mancini A, Geman N, Cho D, Estrellas K, Furtado S, Hopson R, Tripathi A, Mathiowitz E.

Macromol Biosci. 2012 Nov;12(11):1555-65. doi: 10.1002/mabi.201200179. Epub 2012 Sep 24.

PMID:
23008096
10.

Diuretic bioactivity optimization of furosemide in rats.

Laulicht B, Tripathi A, Mathiowitz E.

Eur J Pharm Biopharm. 2011 Oct;79(2):314-9. doi: 10.1016/j.ejpb.2011.04.014. Epub 2011 May 5.

PMID:
21571067
11.

Localization of magnetic pills.

Laulicht B, Gidmark NJ, Tripathi A, Mathiowitz E.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2252-7. doi: 10.1073/pnas.1016367108. Epub 2011 Jan 21.

12.

Understanding gastric forces calculated from high-resolution pill tracking.

Laulicht B, Tripathi A, Schlageter V, Kucera P, Mathiowitz E.

Proc Natl Acad Sci U S A. 2010 May 4;107(18):8201-6. doi: 10.1073/pnas.1002292107. Epub 2010 Apr 19.

13.

Are in vivo gastric bioadhesive forces accurately reflected by in vitro experiments?

Laulicht B, Cheifetz P, Tripathi A, Mathiowitz E.

J Control Release. 2009 Mar 4;134(2):103-10. doi: 10.1016/j.jconrel.2008.11.012. Epub 2008 Nov 27.

PMID:
19087887
14.

Evaluation of continuous flow nanosphere formation by controlled microfluidic transport.

Laulicht B, Cheifetz P, Mathiowitz E, Tripathi A.

Langmuir. 2008 Sep 2;24(17):9717-26. doi: 10.1021/la8009332. Epub 2008 Aug 6.

PMID:
18681411

Supplemental Content

Loading ...
Support Center